2-(4-Acetylpiperazin-1-yl)-N'-hydroxyacetimidamide

Catalog No. :
ACHSMA318
CAS No. :
280110-89-6
Molecular Formula :
C8H16N4O2
Molecular Weight :
200.24

IUPAC Name:(Z)-2-(4-acetylpiperazin-1-yl)-N'-hydroxyacetimidamide

2-(4-Acetylpiperazin-1-yl)-N'-hydroxyacetimidamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$93.00Login to see priceInquiryInquiry
100mg97%$131.00Login to see priceInquiryInquiry
250mg97%$179.00Login to see priceInquiryInquiry
1g97%$447.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Acetylpiperazin-1-yl)-N'-hydroxyacetimidamide
IUPAC Name(Z)-2-(4-acetylpiperazin-1-yl)-N'-hydroxyacetimidamide
MDL No.MFCD14705838
Molecular FormulaC8H16N4O2
Molecular Weight200.24
SMILESN/C(CN1CCN(C(C)=O)CC1)=N\O
InChI KeyIEJDZGDFCZAFEU-UHFFFAOYSA-N
Synonym2-(4-Acetylpiperazin-1-yl)-N-hydroxyethanimidamide;1-Piperazineethanimidamide, 4-acetyl-N-hydroxy-
CAS No.280110-89-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHSMA318 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBNDG182 route compound structure diagram
    ACBNDG18213889-98-0 In Stock
  2. Plus
  3. ACEPDO413 route compound structure diagram
    ACEPDO4133272-96-6 In Stock
  4. Then
  5. ACHSMA318 route product structure diagram
    ACHSMA318280110-89-6
Inquiry

2. ACHSMA318 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBNDG182 route compound structure diagram
    ACBNDG18213889-98-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHSMA318 route product structure diagram
    ACHSMA318280110-89-6
Inquiry

Comments (0)